Cardiothoracic surgeon Timothy W. Mullett, medical director of the Markey Cancer Center Affiliate Network, was named chair of the Commission on Cancer of the American College of Surgeons.
Donna D. Zhang, of University of Arizona Health Sciences, has received an eight-year, $7.3 million grant from the National Institute of Environmental Health Sciences to determine how a family of proteins can be harnessed to prevent or treat arsenic-induced lung cancer and Type 2 diabetes.
Tensions are running high, the soul of the country is at stake, the pandemic is afoot, the Thanksgiving dinner is in doubt, and winter is on its way to Cleveland, where I live.
The future of American health care, pandemic response, and sustained funding for cancer research hangs in the balance as the final votes are being counted and legal challenges launched in the 2020 presidential election.
As he watches COVID-19 numbers climb in New Jersey, Steven K. Libutti reviews all the things he had learned last spring, when the pandemic first slammed the state.
November is Lung Cancer Awareness Month, a time to turn our attention to an issue that already warrants our focus year-round.
A cancer pioneer, Helene G. Brown had coined the name for her peculiar subspecialty: political oncology.
Opdivo (nivolumab) in combination with Yervoy (ipilimumab) received FDA approval for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery.
Regeneron has submitted a request to FDA for Emergency Use Authorization approval for the
FDA has issued draft guidance encouraging the inclusion of premenopausal women in breast cancer clinical trials that investigate the efficacy of hormonal drug and biological products.
